Pathstone Family Office, LLC Vertex Pharmaceuticals Inc Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 15,820 shares of VRTX stock, worth $7.44 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

15,820

Previous 7,093 123.04%

Holding current value

$7.44 Million

Previous $2.5 Million 120.39%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $2.95 Million - $3.16 Million	8,727 Added 123.04%	15,820 $5.5 Million
Q2 2023 Jan 12, 2024	SELL	$314.42 - $351.91 $2.74 Million - $3.07 Million	-8,726 Reduced 55.16%	7,094 $2.5 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $25,782 - $28,856	-82 Reduced 1.14%	7,093 $2.5 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $1.81 Million - $2.06 Million	-6,389 Reduced 47.1%	7,175 $2.26 Million
Q4 2022 Oct 23, 2023	BUY	$285.76 - $321.48 $1.76 Million - $1.98 Million	6,154 Added 83.05%	13,564 $3.92 Million

Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $204,604 - $230,179	-716 Reduced 5.01%	13,564 $3.92 Million
Q3 2022 Oct 23, 2023	BUY	$273.83 - $305.53 $804,786 - $897,952	2,939 Added 65.73%	7,410 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $956,762 - $1.07 Million	3,494 Added 32.39%	14,280 $4.14 Million
Q2 2022 Oct 23, 2023	SELL	$234.96 - $292.55 $616,065 - $767,066	-2,622 Reduced 36.97%	4,471 $1.26 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $1.6 Million - $2 Million	6,821 Added 172.03%	10,786 $3.04 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $114,695 - $135,182	-518 Reduced 11.55%	3,965 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $329,415 - $415,840	1,861 Added 70.98%	4,483 $985,000
Q3 2021 Nov 16, 2021	BUY	$181.39 - $202.99 $60,402 - $67,595	333 Added 14.55%	2,622 $475,000
Q2 2021 Aug 31, 2021	BUY	$187.49 - $221.1 $58,684 - $69,204	313 Added 15.84%	2,289 $462,000
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $284,652 - $331,801	1,375 Added 228.79%	1,976 $425,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $18,837 - $25,124	91 Added 17.84%	601 $142,000
Q1 2020 Jun 11, 2020	BUY	$199.77 - $247.81 $89,696 - $111,266	449 Added 736.07%	510 $122,000
Q1 2020 May 07, 2020	SELL	$199.77 - $247.81 $37,556 - $46,588	-188 Reduced 75.5%	61 $14.5 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $40,768 - $48,480	249 New	249 $46,000

Others Institutions Holding VRTX

# of Institutions

1,624

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Vertex Pharmaceuticals Inc Transaction History